card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Event / Conference

Antibody Therapeutics Xchange West Coast


Event Date

September 25, 2023 to September 26, 2023

Location

San Francisco, CA USA


Home / Events

About this event

Join the Q2 Solutions’ Discovery Sciences team at West Coast Xchange.

 

Both Fortunato Ferrera, Vice President of Antibody Discovery at Specifica Biosciences, and Sofie Pattyn, CTO and Founder of ImmunXperts, will be leading roundtable discussions.

 

  • Fortunato will present from 11:20-12:20 in the group. He’ll present in the Target Selection track on Generating drug-like antibodies from in vitro platforms.
  • Sofie will present from 11:20-12:20 in the Lead Identification & Optimization track on Early immunogenicity risk assessment and functional testing of biotherapeutics.